BEIGF
Price
$25.29
Change
+$0.37 (+1.48%)
Updated
Nov 10 closing price
Capitalization
35.81B
Intraday BUY SELL Signals
CING
Price
$4.04
Change
-$0.02 (-0.49%)
Updated
Dec 24 closing price
Capitalization
27.3M
Intraday BUY SELL Signals
Interact to see
Advertisement

BEIGF vs CING

Header iconBEIGF vs CING Comparison
Open Charts BEIGF vs CINGBanner chart's image
BeOne Medicines
Price$25.29
Change+$0.37 (+1.48%)
Volume$104K
Capitalization35.81B
Cingulate
Price$4.04
Change-$0.02 (-0.49%)
Volume$56.51K
Capitalization27.3M
BEIGF vs CING Comparison Chart in %
BEIGF
Daily Signal:
Gain/Loss:
CING
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BEIGF vs. CING commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEIGF is a Hold and CING is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (BEIGF: $25.29 vs. CING: $4.04)
Brand notoriety: BEIGF and CING are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEIGF: 147% vs. CING: 36%
Market capitalization -- BEIGF: $35.81B vs. CING: $27.3M
BEIGF [@Biotechnology] is valued at $35.81B. CING’s [@Biotechnology] market capitalization is $27.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEIGF’s FA Score shows that 0 FA rating(s) are green whileCING’s FA Score has 0 green FA rating(s).

  • BEIGF’s FA Score: 0 green, 5 red.
  • CING’s FA Score: 0 green, 5 red.
According to our system of comparison, CING is a better buy in the long-term than BEIGF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEIGF’s TA Score shows that 2 TA indicator(s) are bullish while CING’s TA Score has 7 bullish TA indicator(s).

  • BEIGF’s TA Score: 2 bullish, 0 bearish.
  • CING’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, CING is a better buy in the short-term than BEIGF.

Price Growth

BEIGF (@Biotechnology) experienced а 0.00% price change this week, while CING (@Biotechnology) price change was +5.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEIGF($35.8B) has a higher market cap than CING($27.3M). BEIGF has higher P/E ratio than CING: BEIGF (632.37) vs CING (0.02). BEIGF YTD gains are higher at: 80.418 vs. CING (-18.053). BEIGF has higher annual earnings (EBITDA): 339M vs. CING (-19.98M). BEIGF has more cash in the bank: 4.04B vs. CING (6.12M). CING has less debt than BEIGF: CING (4.58M) vs BEIGF (1.02B). BEIGF has higher revenues than CING: BEIGF (4.97B) vs CING (0).
BEIGFCINGBEIGF / CING
Capitalization35.8B27.3M131,136%
EBITDA339M-19.98M-1,697%
Gain YTD80.418-18.053-445%
P/E Ratio632.370.022,611,029%
Revenue4.97B0-
Total Cash4.04B6.12M65,975%
Total Debt1.02B4.58M22,276%
TECHNICAL ANALYSIS
Technical Analysis
BEIGFCING
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
33%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
22%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
14%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
5%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEIGF
Daily Signal:
Gain/Loss:
CING
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAIN59.810.85
+1.44%
Main Street Capital Corp
KTTA1.170.01
+0.86%
Pasithea Therapeutics Corp
BK118.221.00
+0.85%
Bank of New York Mellon Corp
ONTF5.810.04
+0.69%
ON24
EVLV6.66-0.10
-1.48%
Evolv Technologies Holdings

BEIGF and

Correlation & Price change

A.I.dvisor tells us that BEIGF and GOVX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BEIGF and GOVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEIGF
1D Price
Change %
BEIGF100%
N/A
GOVX - BEIGF
29%
Poorly correlated
-4.72%
CING - BEIGF
29%
Poorly correlated
-0.49%
POLBF - BEIGF
25%
Poorly correlated
N/A
XLO - BEIGF
9%
Poorly correlated
+0.47%
CGTX - BEIGF
9%
Poorly correlated
+4.29%
More

CING and

Correlation & Price change

A.I.dvisor tells us that CING and RAPT have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CING and RAPT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CING
1D Price
Change %
CING100%
-0.49%
RAPT - CING
31%
Poorly correlated
+1.24%
ABCL - CING
31%
Poorly correlated
+0.81%
RXRX - CING
30%
Poorly correlated
+0.92%
TRAW - CING
29%
Poorly correlated
+0.81%
BEIGF - CING
29%
Poorly correlated
N/A
More